$664 Million is the total value of Redmile Group, LLC's 50 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 95.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACT | New | ACTAVIS INC | $39,096,000 | – | 271,500 | +100.0% | 5.89% | – |
| AMGN | New | AMGEN INC | $38,698,000 | – | 345,700 | +100.0% | 5.83% | – |
| STJ | New | ST JUDE MED INC | $35,295,000 | – | 658,000 | +100.0% | 5.32% | – |
| GILD | New | GILEAD SCIENCES INC | $33,293,000 | – | 529,800 | +100.0% | 5.01% | – |
| CBST | New | CUBIST PHARMACEUTICALS INC | $28,763,000 | – | 452,600 | +100.0% | 4.33% | – |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $28,648,000 | -10.0% | 471,345 | -0.8% | 4.32% | -23.1% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $25,155,000 | +83.4% | 80,400 | +31.8% | 3.79% | +56.7% |
| THC | Buy | TENET HEALTHCARE CORP | $24,343,000 | +67.0% | 591,000 | +86.9% | 3.67% | +42.8% |
| CTRX | New | CATAMARAN CORP | $23,347,000 | – | 508,100 | +100.0% | 3.52% | – |
| ARIA | Sell | ARIAD PHARMACEUTICALS INC | $23,258,000 | +4.1% | 1,264,009 | -1.0% | 3.50% | -11.0% |
| ARRY | Sell | ARRAY BIOPHARMA INC | $22,825,000 | +5.4% | 3,669,593 | -23.1% | 3.44% | -9.9% |
| PODD | Buy | INSULET CORP | $21,708,000 | +20.6% | 599,000 | +4.5% | 3.27% | +3.0% |
| BKD | Buy | BROOKDALE SR LIVING INC | $19,930,000 | +37.9% | 757,800 | +38.7% | 3.00% | +17.9% |
| PBYI | Sell | PUMA BIOTECHNOLOGY INC | $18,253,000 | -23.8% | 340,165 | -37.0% | 2.75% | -34.9% |
| HCA | Sell | HCA HOLDINGS INC | $17,716,000 | -33.0% | 414,400 | -43.5% | 2.67% | -42.7% |
| NUVA | Sell | NUVASIVE INC | $16,981,000 | -10.3% | 693,392 | -9.2% | 2.56% | -23.4% |
| CELG | Sell | CELGENE CORP | $15,177,000 | -35.4% | 98,600 | -50.9% | 2.29% | -44.8% |
| ZTS | New | ZOETIS INCcl a | $14,499,000 | – | 465,900 | +100.0% | 2.18% | – |
| CMRX | Buy | CHIMERIX INC | $14,368,000 | +31.5% | 653,705 | +45.0% | 2.16% | +12.4% |
| CERS | Sell | CERUS CORP | $13,772,000 | +28.5% | 2,052,400 | -15.4% | 2.07% | +9.8% |
| HTWR | Buy | HEARTWARE INTL INC | $13,553,000 | -12.2% | 185,125 | +14.0% | 2.04% | -25.0% |
| MRK | Buy | MERCK & CO INC NEWcall | $13,450,000 | +15.8% | 282,500 | +13.0% | 2.03% | -1.0% |
| GMED | Buy | GLOBUS MED INCcl a | $12,852,000 | +8.8% | 736,100 | +5.1% | 1.94% | -7.0% |
| CSU | Buy | CAPITAL SR LIVING CORP | $12,633,000 | +25.0% | 597,300 | +41.3% | 1.90% | +6.9% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $12,261,000 | – | 236,100 | +100.0% | 1.85% | – |
| ARTC | New | ARTHROCARE CORP | $12,195,000 | – | 342,759 | +100.0% | 1.84% | – |
| TRNX | Buy | TORNIER N V | $10,981,000 | +14.3% | 568,100 | +3.5% | 1.65% | -2.3% |
| KYTH | Buy | KYTHERA BIOPHARMACEUTICALS I | $10,430,000 | +250.1% | 228,218 | +107.2% | 1.57% | +199.2% |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $8,706,000 | +40.4% | 1,574,379 | -35.8% | 1.31% | +20.1% |
| HWAY | New | HEALTHWAYS INC | $8,569,000 | – | 462,913 | +100.0% | 1.29% | – |
| NSTG | New | NANOSTRING TECHNOLOGIES INC | $8,295,000 | – | 754,132 | +100.0% | 1.25% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $8,208,000 | – | 108,262 | +100.0% | 1.24% | – |
| ARAY | New | ACCURAY INC | $7,935,000 | – | 1,073,799 | +100.0% | 1.20% | – |
| WOOF | Buy | VCA ANTECH INC | $7,908,000 | +9.0% | 288,000 | +3.6% | 1.19% | -6.8% |
| BSTC | Buy | BIOSPECIFICS TECHNOLOGIES CO | $6,360,000 | +30.6% | 326,652 | +4.6% | 0.96% | +11.7% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $5,739,000 | +3.8% | 2,473,787 | +4.2% | 0.86% | -11.4% |
| SSH | New | SUNSHINE HEART INC | $5,453,000 | – | 470,900 | +100.0% | 0.82% | – |
| XON | New | INTREXON CORP | $4,823,000 | – | 203,600 | +100.0% | 0.73% | – |
| VCRA | New | VOCERA COMMUNICATIONS INC | $4,564,000 | – | 245,400 | +100.0% | 0.69% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $4,106,000 | – | 649,700 | +100.0% | 0.62% | – |
| ARRAY BIOPHARMA INCnote 3.000% 6/0 | $3,444,000 | +20.5% | 3,000,000 | 0.0% | 0.52% | +3.0% | ||
| GWPH | New | GW PHARMACEUTICALS PLCads | $2,861,000 | – | 165,020 | +100.0% | 0.43% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $1,485,000 | – | 53,100 | +100.0% | 0.22% | – |
| RCPT | New | RECEPTOS INC | $540,000 | – | 20,800 | +100.0% | 0.08% | – |
| VSTM | New | VERASTEM INC | $386,000 | – | 31,000 | +100.0% | 0.06% | – |
| PPH | MARKET VECTORS ETF TRpharmaceutical | $311,000 | +5.1% | 6,500 | 0.0% | 0.05% | -9.6% | |
| RPRX | New | REPROS THERAPEUTICS INC | $281,000 | – | 10,500 | +100.0% | 0.04% | – |
| AGN | Sell | ALLERGAN INC | $238,000 | -97.8% | 2,627 | -97.9% | 0.04% | -98.1% |
| PRGO | New | PERRIGO CO | $210,000 | – | 1,700 | +100.0% | 0.03% | – |
| MRK | New | MERCK & CO INC NEW | $90,000 | – | 1,900 | +100.0% | 0.01% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -50,000 | -100.0% | -0.01% | – |
| XNPT | Exit | XENOPORT INC | $0 | – | -12,500 | -100.0% | -0.01% | – |
| IDIX | Exit | IDENIX PHARMACEUTICALS INC | $0 | – | -30,200 | -100.0% | -0.02% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -3,200 | -100.0% | -0.04% | – |
| SLXP | Exit | SALIX PHARMACEUTICALS INC | $0 | – | -3,300 | -100.0% | -0.04% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -7,200 | -100.0% | -0.04% | – |
| IBB | Exit | ISHARES TRnasdq bio indx | $0 | – | -1,500 | -100.0% | -0.05% | – |
| CYCC | Exit | CYCLACEL PHARMACEUTICALS INC | $0 | – | -1,077,465 | -100.0% | -0.56% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -38,700 | -100.0% | -0.63% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -255,100 | -100.0% | -0.64% | – |
| OREX | Exit | OREXIGEN THERAPEUTICS INC | $0 | – | -1,190,440 | -100.0% | -1.23% | – |
| ABMD | Exit | ABIOMED INC | $0 | – | -326,189 | -100.0% | -1.24% | – |
| CYBX | Exit | CYBERONICS INC | $0 | – | -139,100 | -100.0% | -1.27% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -580,500 | -100.0% | -1.37% | – |
| WAT | Exit | WATERS CORP | $0 | – | -79,664 | -100.0% | -1.40% | – |
| CPHD | Exit | CEPHEID | $0 | – | -318,900 | -100.0% | -1.93% | – |
| MODN | Exit | MODEL N INC | $0 | – | -484,600 | -100.0% | -2.00% | – |
| VHS | Exit | VANGUARD HEALTH SYS INC | $0 | – | -641,955 | -100.0% | -2.35% | – |
| ZBH | Exit | ZIMMER HLDGS INC | $0 | – | -177,900 | -100.0% | -2.35% | – |
| IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -961,100 | -100.0% | -3.38% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -584,000 | -100.0% | -4.86% | – |
| ONXX | Exit | ONYX PHARMACEUTICALS INC | $0 | – | -393,981 | -100.0% | -6.03% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -1,048,559 | -100.0% | -6.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.